Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2022-01-26 00:00:00 ET · period of report 2022-01-24 · accession 0001209191-22-005078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-26 | 2022-01-24 | TVTX | Dube Eric M | CEO, Dir | S - Sale | $24.98 | -7,873 | 131.7K | -6% | -$196.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-24 | S | D | 7,873 | $24.98 | 131,710 | D | — | — |